In the case of Actavis, Inc (NYSE: ACT), the market cap is now $16.24 billion, versus Mead Johnson Nutrition Co (NYSE: MJN) at $16.10 billion.

Mead Johnson Nutrition announces that P. Kasper Jakobsen is officially named as President and Chief Executive Officer by its Board of Directors immediately following the company's Annual Meeting of Stockholders. Jakobsen succeeds Stephen W. Golsby, ...

Mead Johnson Nutrition (NYSE: MJN), a leading provider of pediatric nutrition products, and Hand to Hold, a national nonprofit Neonatal Intensive Care Unit (NICU) parent support organization, are rolling out the red carpet to recognize health care ...

Mead Johnson Nutrition Co. sees FY2013 EPS of $3.22-3.30, versus the consensus of $3.29. "While still cautious about China/Hong Kong, we remain confident in our 2013 performance,� said Mr. Golsby.

Mead Johnson Nutrition (NYSE: MJN) announced that P. Kasper Jakobsen was officially named as President and Chief Executive Officer by its Board of Directors immediately following the company's Annual Meeting of Stockholders, held today in Chicago.

Mead Johnson Nutrition (MJN) is a global leader in pediatric nutrition and develops, manufacturers, markets, and distributes more than 70 products in over 50 markets worldwide.

Citigroup reported on Tuesday that it has lowered its estimates for Nutrition product company, Mead Johnson Nutrition CO (MJN ). The firm has reduced its earnings estimates through 2014 for MJN.

Mead Johnson Nutrition (NYSE: MJN) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.85 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.85.

Mead Johnson Nutrition (NYSE: MJN) opened at 80.18 on Monday. Mead Johnson Nutrition has a 1-year low of $61.27 and a 1-year high of $88.72.

While Mead Johnson Nutrition Co. has experienced steady growth since its 2009 spinoff from Bristol-Meyers Squibb, its 2013 numbers could be affected by a restriction on infant formula in China, which accounts for 30 percent of the company's sales ...